7FC-33091-45700
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 456 / OH
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Moderna
-
2020-12-30
Registered in v-safe
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-03
- 2021-01-04
- 2021-01-18
-
2021-01-28
Dose 2 — Moderna
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
-
2021-07-31
Survey response — 6 months, dose 2MedDRA: Abnormal uterine bleeding, Thrombosis, Uterine dilation and curettage, Uterine prolapse — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Prolonged excessive uterine bleeding & clotting requiring a D & C & a uterine prolapse.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-28 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-30 | priority 2/3 | |
| 2021-07-31 | Unsuccessful |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 9 — 6 months, dose 2
Symptoms: Prolonged excessive uterine bleeding & clotting requiring a D & C & a uterine prolapse.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal uterine bleeding | ✓ | · | ✓ |
| SD | Thrombosis | ✓ | · | ✓ |
| SD | Uterine dilation and curettage | ✓ | · | ✓ |
| SD | Uterine prolapse | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release